# Comprehensive identification of pathogenic tandem repeat expansions in sporadic amyotrophic lateral sclerosis: advantages of long-read vs. short-read sequencing

**Authors:** Eleonora Sabetta, Karin Rallmann, Jonas Bergquist, Pille Taba, Abigail L. Pfaff, Bal Hari Poudel, Davide Ferrari, Massimo Locatelli, Sulev Kõks

PMC · DOI: 10.3389/ebm.2025.10593 · Experimental Biology and Medicine · 2025-07-17

## TL;DR

This study compares long-read and short-read sequencing for identifying genetic mutations in sporadic ALS, finding long-read sequencing more effective.

## Contribution

Demonstrates the superiority of long-read sequencing over short-read sequencing in detecting pathogenic tandem repeat expansions in sporadic ALS.

## Key findings

- Short-read sequencing identified expansions in HTT, ATXN2, and CACNA1A genes in one patient, but these were not confirmed by long-read sequencing.
- Long-read sequencing detected a large C9orf72 expansion missed by short-read sequencing.
- Long-read sequencing is more accurate for identifying pathogenic tandem repeat expansions in ALS.

## Abstract

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder presenting progressive weakness of the bulbar and extremity muscles, leading to a wide-ranging clinical phenotype. More than 30 genes have been associated to genetically inherited ALS yet, approximately 85%–90% of ALS cases are sporadic. Short tandem repeats expansions, have recently been found in clinically diagnosed ALS patients and are currently investigated as potential genetic biomarkers. In this paper we compare the investigation of pathological tandem repeat expansions on a group of ALS patients by comparing the standard short-read sequencing (SRS) technique with a long-read-sequencing (LRS) method which has recently become more accessible. Blood samples from 47 sporadic ALS cases were subjected to SRS by Illumina Whole Genome Sequencing. The genome-wide tandem repeat expansions were genotyped using GangSTR, while wANNOVAR was used for variant annotation. Uncertain cases were further explored using LRS. SRS identified pathological expansions in HTT, ATXN2, and CACNA1A genes in one patient, which were not confirmed with LRS. The latter identified large tandem repeat expansions in the C9orf72 gene of one patient that were missed by SRS. Our findings suggest that LRS should be preferred to SRS for accurate identification of pathological tandem repeat expansions.

## Linked entities

- **Genes:** HTT (huntingtin) [NCBI Gene 3064], ATXN2 (ataxin 2) [NCBI Gene 6311], CACNA1A (calcium voltage-gated channel subunit alpha1 A) [NCBI Gene 773], C9orf72 (C9orf72-SMCR8 complex subunit) [NCBI Gene 203228]
- **Diseases:** amyotrophic lateral sclerosis (MONDO:0004976), ALS (MONDO:0004976)

## Full-text entities

- **Genes:** IGHD1-7 (immunoglobulin heavy diversity 1-7) [NCBI Gene 28509] {aka DM1, IGHD17}, PPP2R2B (protein phosphatase 2 regulatory subunit Bbeta) [NCBI Gene 5521] {aka B55BETA, PP2AB55BETA, PP2ABBETA, PP2APR55B, PP2APR55BETA, PR2AB55BETA}, ATXN8 (ataxin 8) [NCBI Gene 724066], TARDBP (TAR DNA binding protein) [NCBI Gene 23435] {aka ALS10, TDP-43}, TBP (TATA-box binding protein) [NCBI Gene 6908] {aka GTF2D, GTF2D1, HDL4, SCA17, TBP1, TFIID}, ATXN1 (ataxin 1) [NCBI Gene 6310] {aka ATX1, D6S504E, SCA1}, SOD1 (superoxide dismutase 1) [NCBI Gene 6647] {aka ALS, ALS1, HEL-S-44, IPOA, SOD, STAHP}, CACNA1A (calcium voltage-gated channel subunit alpha1 A) [NCBI Gene 773] {aka APCA, BI, CACNL1A4, CAV2.1, DEE42, EA2}, HTT (huntingtin) [NCBI Gene 3064] {aka HD, IT15, LOMARS}, ATXN7 (ataxin 7) [NCBI Gene 6314] {aka ADCAII, OPCA3, SCA7, SGF73}, FMR1 (fragile X messenger ribonucleoprotein 1) [NCBI Gene 2332] {aka FMRP, FRAXA, POF, POF1}, ATXN3 (ataxin 3) [NCBI Gene 4287] {aka AT3, ATX3, JOS, MJD, MJD1, SCA3}, ATXN8OS (ATXN8 opposite strand lncRNA) [NCBI Gene 6315] {aka KLHL1AS, NCRNA00003, SCA8}, ATXN2 (ataxin 2) [NCBI Gene 6311] {aka ATX2, SCA2, TNRC13}, C9orf72 (C9orf72-SMCR8 complex subunit) [NCBI Gene 203228] {aka ALSFTD, DENND9, DENNL72, FTDALS, FTDALS1}, FUS (FUS RNA binding protein) [NCBI Gene 2521] {aka ALS6, ETM4, FUS1, HNRNPP2, POMP75, TLS}
- **Diseases:** Cognitive impairment (MESH:D003072), FTD (MESH:D057180), LRS (MESH:D004410), neurodegenerative disease (MESH:D019636), ALS (MESH:D000690), paralysis (MESH:D010243), weakness (MESH:D018908), Huntington's disease (MESH:D006816), motor neuron disease (MESH:D016472), SLIDINGWINDOW:4:15 (MESH:D012559), anxiety (MESH:D001007), DM1-AS (MESH:D009223), extremity muscles (MESH:D009135), dementia syndrome (MESH:D003704)
- **Chemicals:** polyglutamine-associated disorders (-), lead (MESH:D007854)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12310560/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12310560/full.md

## References

48 references — full list in the complete paper: https://tomesphere.com/paper/PMC12310560/full.md

---
Source: https://tomesphere.com/paper/PMC12310560